Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1576
SiriusXM
SIRI
$8.67B
| $11.5M | ﹤0.01% |
575,697
+336,269
| +140% | +$7.23M |
2013 Q2
50 quarters
|
|
1577
CACI
CACI
$13.6B
| $11.5M | ﹤0.01% |
21,579
-31,137
| -59% | -$17.6M |
2013 Q2
50 quarters
|
|
1578
Columbia Banking Systems
COLB
$8.18B
| $11.5M | ﹤0.01% |
411,049
-1,050,822
| -72% | -$28.4M |
2016 Q3
37 quarters
|
|
1579
Modine Manufacturing
MOD
$9.46B
| $11.5M | ﹤0.01% |
86,027
+8,659
| +11% | +$1.29M |
2013 Q2
50 quarters
|
|
1580
Seaboard Corp
SEB
$3.85B
| $11.5M | ﹤0.01% |
2,580
-116
| -4% | -$459K |
2020 Q2
22 quarters
|
|
1581
ONE Gas
OGS
$4.56B
| $11.4M | ﹤0.01% |
148,072
-21,243
| -13% | -$1.71M |
2014 Q1
47 quarters
|
|
1582
PUT
Marathon Petroleum
MPC
$119B
| $11.4M | ﹤0.01% |
70,300
| – | – |
2024 Q3
5 quarters
|
|
1583
Cogent Biosciences
COGT
$5.38B
| $11.4M | ﹤0.01% |
321,606
-38,224
| -11% | -$1.07M |
2022 Q1
15 quarters
|
|
1584
CALL
Avis
CAR
$3.93B
| $11.4M | ﹤0.01% |
89,000
+400
| +0.5% | +$55.8K |
2025 Q3
1 quarter
|
|
1585
HubSpot
HUBS
$10.7B
| $11.4M | ﹤0.01% |
28,435
+4,361
| +18% | +$1.81M |
2014 Q4
44 quarters
|
|
1586
CALL
e.l.f. Beauty
ELF
$6.18B
| $11.4M | ﹤0.01% |
150,000
| – | – |
2025 Q2
2 quarters
|
|
|
1587
PUT
e.l.f. Beauty
ELF
$6.18B
| $11.4M | ﹤0.01% |
150,000
| – | – |
2025 Q2
2 quarters
|
|
1588
Black Hills Corp
BKH
$5.41B
| $11.4M | ﹤0.01% |
164,079
-2,298
| -1% | -$155K |
2013 Q2
50 quarters
|
|
1589
BCE
BCE
$18.4B
| $11.4M | ﹤0.01% |
477,586
+174,082
| +57% | +$4.05M |
2013 Q2
50 quarters
|
|
1590
Arcosa
ACA
$7.19B
| $11.4M | ﹤0.01% |
106,915
+12,630
| +13% | +$1.27M |
2018 Q4
28 quarters
|
|
1591
Enovix
ENVX
$614M
| $11.3M | ﹤0.01% |
1,551,941
+1,124,480
| +263% | +$10.9M |
2022 Q1
15 quarters
|
|
1592
CALL
American International
AIG
$39.2B
| $11.3M | ﹤0.01% |
+132,500
| New | +$10.6M |
2025 Q4
0 quarters
|
|
1593
CALL
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $11.3M | ﹤0.01% |
210,700
+57,200
| +37% | +$3.11M |
2025 Q1
3 quarters
|
|
1594
New York Times
NYT
$10.1B
| $11.3M | ﹤0.01% |
163,089
-59,383
| -27% | -$3.68M |
2013 Q2
50 quarters
|
|
1595
Toast
TOST
$17.2B
| $11.3M | ﹤0.01% |
318,804
+40,218
| +14% | +$1.45M |
2022 Q1
15 quarters
|
|
|
KALV
1596
DELISTED
KalVista Pharmaceuticals
KALV
| $11.3M | ﹤0.01% |
700,573
+122,669
| +21% | +$1.62M |
2018 Q3
29 quarters
|
|
1597
Trupanion
TRUP
$1.03B
| $11.3M | ﹤0.01% |
302,625
-77,267
| -20% | -$3.03M |
2016 Q2
38 quarters
|
|
1598
Atour Lifestyle Holdings
ATAT
$4.39B
| $11.3M | ﹤0.01% |
286,805
+204,186
| +247% | +$8M |
2022 Q4
12 quarters
|
|
1599
Quantum Computing Inc
QUBT
$1.85B
| $11.3M | ﹤0.01% |
1,100,974
+851,034
| +340% | +$12.1M |
2025 Q1
3 quarters
|
|
1600
KBR
KBR
$4.32B
| $11.3M | ﹤0.01% |
280,984
+111,303
| +66% | +$4.77M |
2013 Q2
50 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.